sulfisoxazole has been researched along with furosemide in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (38.10) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 4 (19.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Prandota, J; Pruitt, AW | 1 |
Poland, RL; Shankaran, S | 1 |
Ahlfors, CE; Rasmussen, F; Wennberg, RP | 1 |
d'Athis, P; Hoareau, A; Tillement, JP; Zini, R | 1 |
Brater, DC; Kirchner, KA; Voelker, JR | 1 |
Benet, LZ; Gloff, CA; Mamelok, RD | 1 |
Brodersen, R; Cashore, WJ; Oh, W | 1 |
Benet, LZ; Smith, DE | 1 |
Bank, N; Lief, PD; Mutz, BF | 1 |
Johnson, KL; Kalish, RS; LaPorte, A; Wood, JA | 1 |
Agarwal, R; Brater, DC; Gorski, JC; Sundblad, K | 1 |
1 review(s) available for sulfisoxazole and furosemide
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
1 trial(s) available for sulfisoxazole and furosemide
Article | Year |
---|---|
Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.
Topics: Adult; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Diuretics; Female; Furosemide; Humans; Male; Middle Aged; Nephrotic Syndrome; Protein Binding; Sodium; Sulfisoxazole; Urine | 2000 |
19 other study(ies) available for sulfisoxazole and furosemide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Furosemide binding to human albumin and plasma of nephrotic children.
Topics: Acetazolamide; Aspirin; Child; Diazoxide; Dose-Response Relationship, Drug; Female; Furosemide; Humans; Hydrogen-Ion Concentration; Male; Nephrotic Syndrome; Phenylbutazone; Phosphates; Protein Binding; Renal Dialysis; Serum Albumin; Sulfisoxazole; Temperature; Time Factors; Tolbutamide | 1975 |
The displacement of bilirubin from albumin by furosemide.
Topics: Animals; Azo Compounds; Benzoates; Bilirubin; Binding Sites; Blood; Chemical Fractionation; Coloring Agents; Furosemide; Jaundice; Protein Binding; Rats; Serum Albumin; Sulfisoxazole | 1977 |
Displacement of bilirubin from human albumin by three diuretics.
Topics: Bilirubin; Binding, Competitive; Chlorothiazide; Chromatography, Gel; Diuretics; Erythrocytes; Ethacrynic Acid; Furosemide; Humans; Peroxidases; Protein Binding; Serum Albumin; Sulfisoxazole | 1977 |
Binding of four sulphonamides to human albumin.
Topics: Acenocoumarol; Binding Sites; Binding, Competitive; Furosemide; Humans; In Vitro Techniques; Kinetics; Phenindione; Protein Binding; Serum Albumin; Sulfisoxazole; Sulfonamides; Tolbutamide | 1976 |
Binding inhibitors restore furosemide potency in tubule fluid containing albumin.
Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Body Fluids; Dansyl Compounds; Drug Tolerance; Furosemide; Kidney Tubules, Distal; Male; Nephrotic Syndrome; Perfusion; Protein Binding; Rats; Rats, Inbred Strains; Sarcosine; Sulfisoxazole; Warfarin | 1991 |
Organic anion transport by basal-lateral membranes: effect of PAH and furosemide on each other's transport.
Topics: Aminohippuric Acids; Animals; Binding, Competitive; Biological Transport, Active; Furosemide; In Vitro Techniques; Kidney; Membranes; p-Aminohippuric Acid; Probenecid; Rabbits; Sulfisoxazole | 1988 |
Bilirubin-displacing effect of furosemide and sulfisoxazole. An in vitro and in vivo study in neonatal serum.
Topics: Bilirubin; Binding, Competitive; Dapsone; Furosemide; Horseradish Peroxidase; Humans; In Vitro Techniques; Infant, Newborn; Kinetics; Oxidation-Reduction; Protein Binding; Sulfisoxazole | 1983 |
Plasma protein binding of furosemide in kidney transplant patients.
Topics: Blood Proteins; Drug Interactions; Furosemide; Humans; Kidney; Kidney Transplantation; Protein Binding; Sulfisoxazole | 1982 |
Diuretics stimulate H+ secretion in turtle urinary bladder.
Topics: Animals; Borates; Chlorothiazide; Cysteine; Diuretics; Electric Conductivity; Ethacrynic Acid; Furosemide; Hydrochlorothiazide; Hydrogen; Hydrogen-Ion Concentration; In Vitro Techniques; Mucous Membrane; Sodium; Sulfisoxazole; Time Factors; Turtles; Urinary Bladder | 1980 |
Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions.
Topics: Adult; Aged; Cells, Cultured; Drug Eruptions; Female; Furosemide; Humans; Lymphocyte Activation; Male; Middle Aged; Sulfisoxazole; T-Lymphocytes; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |